News

News and updates in the research and development of digital biomarkers and wearable sensor technologies.

Events

July 14 - 17 2024

ALS Nexus

Dallas, TX
ALS Nexus brings together leaders in the ALS community to connect, collaborate, and change the future of ALS. This is more than a conference – it’s an opportunity to spark new ideas and accelerate progress towards our goal of making ALS a livable disease until we can cure it.

News

January 24, 2023

$2.5M NIH Award to Develop a Multi-Modal Remote Monitoring Solution for FTLD Syndromes

BioSensics is pleased to announce a $2.5M/2-year award from the U.S. National Institute of Health (NIH) to develop a robust multi-modal solution for remote monitoring of motor, speech, and cognitive function in Frontotemporal lobar degeneration (FTLD) syndromes.
Read more

November 30, 2022

NIH Selects BioSensics to Develop Remote Measurement Technologies for Rare Diseases

BioSensics has been selected by the U.S. National Institute of Health to develop remote measurement technologies for use in clinical trials in individuals with rare diseases.
Read more

November 14, 2022

$2.5M NIH Award to Develop a Multi-Modal Monitoring Solution for Myasthenia Gravis

BioSensics has been awarded a $2.5M/3-year NIH award to develop a multi-modal monitoring solution of myasthenia gravis.
Read more

November 2, 2022

Upper Extremity Motor Assessment in Ataxia | ICAR 2022

Upper Extremity Motor Assessment in Ataxia using BioSensics Wearable Sensors
Read more

October 17, 2022

PAMSys as Secondary Endpoint for MSA | Digital Biomarkers Summit

PAMSys is used as a secondary endpoint in a Phase 2 trial in Multiple System Atrophy.
Read more